Angionetics

Angionetics: A Developer of Biotechnology Products for Heart Problems. The company is dedicated to the development and commercialization of novel DNA-based therapies aimed at promoting the heart's innate natural ability to regulate the formation and growth of cardiac microvascular circulation, thereby enhancing blood flow in patients with various ischemia-driven and refractory conditions caused by cardiac microvascular dysfunction (CMI) and other cardiovascular diseases, such as angina and myocardial ischemia.